5HZ5 | Lipid Binding Protein | date | Feb 02, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Fabp5 In Complex With 6-Chloro-4-Phenyl-2-Piperidin-1-Yl-3-( Tetrazol-5-Yl)-Quinoline | ||||||||||||||
authors | A.Ehler, M.G.Rudolph | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Fatty Acid-Binding Protein, Epidermal Chain: A Fragment: Soluble Form, Residues 2-135 Synonym: Epidermal-Type Fatty Acid-Binding Protein,E-Fabp,F Binding Protein 5,Psoriasis-Associated Fatty Acid-Binding P Homolog,Pa-Fabp; Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Fabp5 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 Expression_system_vector_type: Plasmid | ||||||||||||||
symmetry | Space Group: P 43 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.40 Å | ||||||||||||
ligand | 65X, DMS, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors., Kuhne H, Obst-Sander U, Kuhn B, Conte A, Ceccarelli SM, Neidhart W, Rudolph MG, Ottaviani G, Gasser R, So SS, Li S, Zhang X, Gao L, Myers M, Bioorg Med Chem Lett. 2016 Oct 15;26(20):5092-5097. doi:, 10.1016/j.bmcl.2016.08.071. Epub 2016 Aug 22. PMID:27658368 |
Data retrieval |
View 5HZ5 in 3D |
Visual 3D analysis of 5HZ5 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5HZ5 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |